Speciality Interests

Acute kidney disease and onconephrology, diabetic or hypertensive kidney disease, glomerulonephritis, autosomal dominant polycytic kidney disease, peritoneal dialysis

Schedule

schedule of week
05 THU
01
FRI
02
MON
05
TUE
06
WEN
07
AM
PM

Medical School

2019~2022 Ph.D. in Medicine, Sungkyunkwan University School of Medicin, Korea 2017~2019 Master of Science, Sungkyunkwan University School of Medicin, Korea 2000~2006 Medical Doctor, College of Medicine, Sungkyunkwan University School of Medicine, Korea

Specialty Training

Specialty Training
Fellowship   2017~2020 Division of Nephrology, Samsung Medical Center, Korea
Residency   2007~2011 Department of Medicine, Samsung Medical Center, Korea
Internship   2006~2007 Samsung Medical Center, Korea

Other Education

  • 2022~Present Clinical Associate Professor, Division of Nephrology, Samsung Medical Center
    2020~2022 Clinical Instructor, Division of Nephrology, Samsung Medical Center

Participation in Academic Societies
and Research

  • Member, The Korean Association of Internal Medicine
    Member, The Korean Society of Nephrology
    Member, The Korean Society of Transplantation

Thesis

  • J HYPERTENS 2025 10.1097/HJH.0000000000003938 Resolution of hypertension after kidney transplantation is associated with improved kidney transplant outcomes: a nationwide cohort study Lee, K; Kim, BS; Jeon, J; Shin, DW; Lee, JE; Huh, W; Han, KD; Jang, HR
    View PubMed
  • CLIN KIDNEY J 2025 10.1093/ckj/sfae354 Urinary RANTES and MCP-1 as noninvasive biomarkers for differential diagnosis and prediction of treatment response in acute interstitial nephritis Baeg, SI; Lee, K; Jeon, J; Lee, JE; Kwon, GY; Huh, W; Jang, HR
    View PubMed
  • RENAL FAILURE 2024 10.1080/0886022X.2024.2401623 Clinical impact of diastolic dysfunction and atrial fibrillation before and after initiating hemodialysis in patients with end-stage kidney disease Jeon, H; Jeon, J; Lee, K; Kim, J; Kim, D; Lee, JE; Huh, W; Jang, HR
    View PubMed
  • CELL MOL LIFE SCI 2024 10.1007/s00018-024-05493-9 Transcriptome and epigenome dynamics of the clonal heterogeneity of human induced pluripotent stem cells for cardiac differentiation Yun, J; So, JM; Jeong, S; Jang, J; Han, S; Jeon, J; Lee, K; Jang, HR; Lee, J
    View PubMed
  • KIDNEY INT REP 2024 10.1016/j.ekir.2024.09.022 Renal Outcomes With Renin-Angiotensin System Blockers After Unilateral Nephrectomy Lee, S; Yoon, S; Kim, S; Jeon, H; Lee, K; Jang, HR; Lee, JE; Huh, W; Jeon, J
    View PubMed
  • INT J STROKE 2024 10.1177/17474930241295890 Elevated risk of end-stage kidney disease in stroke patients: A population-based observational study Chun, S; Han, K; Kim, B; Lee, D; Cho, IY; Choi, HL; Park, JH; Jeon, J; Jang, HR; Shin, DW
    View PubMed
  • AM J NEPHROL 2024 10.1159/000541832 Kidney and Cardiovascular Outcomes in Older Population with Mildly to Moderately Decreased Kidney Function: A Nationwide Cohort Study Jeon, J; Shin, DW; Park, SH; Jung, JH; Lee, K; Lee, JE; Huh, W; Han, K; Jang, HR
    View PubMed
  • KIDNEY RES CLIN PRAC 2024 10.23876/j.krcp.23.308 Validation of prediction model for successful discontinuation of continuous renal replacement therapy: a multicenter cohort study Jeon, J; Ko, EJ; Park, H; Baeg, SI; Kim, HD; Min, JW; Koh, ES; Lee, K; Kang, D; Cho, J; Lee, JE; Huh, W; Ha Chung, B; Jang, HR
    View PubMed
  • J NEPHROL 2024 10.1007/s40620-024-02027-1 Prediction of post-donation renal function using machine learning techniques and conventional regression models in living kidney donors Jeon, J; Song, Y; Yu, JY; Jung, W; Lee, K; Lee, JE; Huh, W; Cha, WC; Jang, HR
    View PubMed
  • CLIN KIDNEY J 2024 10.1093/ckj/sfae116 Effects of Kt/Vurea on outcomes according to age in patients on maintenance hemodialysis Jeon, J; Kim, GO; Kim, BY; Son, EJ; Do, JY; Lee, JE; Kang, SH
    View PubMed
  • CLIN TRANSPLANT 2024 10.1111/ctr.15308 Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study Kim, S; Jung, JH; Lee, K; Jeon, J; Shin, DW; Jang, HR; Lee, JE; Han, K; Huh, W
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-56772-1 Impact of anemia requiring transfusion or erythropoiesis-stimulating agents on new-onset cardiovascular events and mortality after continuous renal replacement therapy Jeon, J; Kang, D; Park, H; Lee, K; Lee, JE; Huh, W; Cho, J; Jang, HR
    View PubMed
  • FRONT BIOENG BIOTECH 2024 10.3389/fbioe.2024.1367141 PIV-MyoMonitor: an accessible particle image velocimetry-based software tool for advanced contractility assessment of cardiac organoids Lee, H; Kim, B; Yun, J; Bae, J; Park, S; Jeon, J; Jang, HR; Lee, J; Lee, S
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-023-50630-2 Effects of poly (ADP-ribose) polymerase inhibitor treatment on the repair process of ischemic acute kidney injury Jeon, J; Lee, K; Jang, HR; Yang, KE; Lee, CJ; Ahn, H; Park, WY; Lee, JE; Kwon, GY; Kim, YG; Huh, W
    View PubMed
  • RENAL FAILURE 2023 10.1080/0886022X.2022.2157285 The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device Jeon, H; Jeon, J; Lee, K; Kim, D; Cho, YH; Lee, JE; Choi, JO; Huh, W; Kim, YG; Jeon, ES; Jang, HR
    View PubMed
  • FRONT MED-LAUSANNE 2023 10.3389/fmed.2023.1222973 Prediction tool for renal adaptation after living kidney donation using interpretable machine learning Jeon, J; Yu, JY; Song, Y; Jung, W; Lee, K; Lee, JE; Huh, W; Cha, WC; Jang, HR
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-32305-0 Prognostic significance of albuminuria in elderly of various ages with diabetes Hwang, S; Lee, KYH; Park, J; Kim, D; Jeon, J; Jang, HR; Hur, KY; Kim, JH; Huh, W; Kim, YG; Lee, JE
    View PubMed
  • NEPHROL DIAL TRANSPL 2023 10.1093/ndt/gfad016 Acute kidney injury in bortezomib-treated patients with multiple myeloma Song, SM; Jeon, J; Jang, HR; Kim, K; Huh, W; Kim, YG; Lee, JE
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-022-26964-8 Increased end-stage renal disease risk in age-related macular degeneration: a nationwide cohort study with 10-year follow-up Jung, W; Park, J; Jang, HR; Jeon, J; Han, K; Kim, B; Yoon, JM; Lim, DH; Shin, DW
    View PubMed
  • KIDNEY RES CLIN PRAC 2022 10.23876/j.krcp.21.246 Clinical relevance of postoperative proteinuria for prediction of early renal outcomes after kidney transplantation Jun, JS; Park, K; Lee, HS; Lee, KW; Lee, JE; Park, JB; Kim, K; Huh, W; Kim, YG; Kim, DJ; Jang, HR
    View PubMed
  • TRANSPL INT 2022 10.3389/ti.2022.10714 Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation Lee, KW; Sim, J; Park, SSW; Jeon, J; Kim, G; Kim, MJ; Kwon, GY; Jang, HR; Huh, W; Park, JB
    View PubMed
  • FRONT MED-LAUSANNE 2022 10.3389/fmed.2022.915072 Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy Baeg, SI; Jeon, J; Kang, D; Na, SJ; Cho, J; Kim, K; Yang, JH; Chung, CR; Lee, JE; Huh, W; Suh, GY; Kim, YG; Kim, DJ; Jang, HR
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-15906-z Depression is a main determinant of health-related quality of life in patients with diabetic kidney disease Kim, S; Jeon, J; Lee, YJ; Jang, HR; Joo, EY; Huh, W; Kim, YG; Kim, DJ; Lee, JE
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-13261-7 Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis Jeon, J; Park, J; Boo, HJ; Yang, KE; Lee, CJ; Lee, JE; Kim, K; Kwon, GY; Huh, W; Kim, DJ; Kim, YG; Jang, HR
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11092392 Impact of Renal Replacement Therapy on Mortality and Renal Outcomes in Critically Ill Patients with Acute Kidney Injury: A Population-Based Cohort Study in Korea between 2008 and 2015 Hwang, S; Kang, D; Park, H; Kim, Y; Guallar, E; Jeon, J; Lee, JE; Huh, W; Suh, GY; Cho, J; Jang, HR
    View PubMed
  • AM J TRANSL RES 2022 Repair phase modeling of ischemic acute kidney injury: recovery vs. transition to chronic kidney disease Lee, K; Jang, HR; Jeon, J; Yang, KE; Lee, JE; Kwon, GY; Kim, DJ; Kim, YG; Huh, W
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10215110 Prognostic Factors of Renal Outcomes after Heart Transplantation: A Nationwide Retrospective Study Jeon, J; Park, H; Kim, Y; Kang, D; Lee, JE; Huh, W; Guallar, E; Cho, J; Jang, HR
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-98135-0 Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study Jang, HR; Kim, M; Hong, S; Lee, K; Park, MY; Yang, KE; Lee, CJ; Jeon, J; Lee, KW; Lee, JE; Park, JB; Kim, K; Kwon, GY; Kim, YG; Kim, DJ; Huh, W
    View PubMed
  • INT HEART J 2021 10.1536/ihj.20-775 Clinical Factors Associated with Renal Outcome After Heart Transplantation Jeon, J; Kwon, HJ; Yoo, H; Kim, D; Cho, YH; Choi, JO; Kim, K; Sung, K; Jang, HR
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90311-6

    Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial

    Lee1, Y; Jang, MJ; Jeon, J; Lee, JE; Huh, W; Choi, BS; Park, CW; Chin, HJ; Kang, CL; Kim, DK; Han, SS; Joo, KW

    BLOOD PURIFICAT 2021 10.1159/000512350

    A Scoring Model with Simple Clinical Parameters to Predict Successful Discontinuation of Continuous Renal Replacement Therapy

    Baeg1, SI; Jeon, J; Yoo, H; Na, SJ; Kim, K; Chung, CR; Yang, JH; Jeon, K; Lee, JE; Huh, W; Suh, GY; Kim, YG; Kim, DJ; Jang, HR

    FRONT IMMUNOL 2021 10.3389/fimmu.2021.621176

    Dietary Modification Alters the Intrarenal Immunologic Micromilieu and Susceptibility to Ischemic Acute Kidney Injury

    Jeon1, J; Lee, K; Yang, KE; Lee, JE; Kwon, GY; Huh, W; Kim, DJ; Kim, YG; Jang, HR

    RENAL FAILURE 2021 10.1080/0886022X.2021.1940202

    Predialysis predictors for identifying patients requiring dialysis at a higher glomerular filtration rate

    Jeon1, J; Jang, HR; Huh, W; Kim, YG; Kim, DJ; Lee, JE

    FRONT CELL DEV BIOL 2021 10.3389/fcell.2020.618796

    Modeling Uremic Vasculopathy With Induced Pluripotent Stem Cell-Derived Endothelial Cells as a Drug Screening System

    Jang1, HR; Cho, HJ; Zhou, Y; Shao, NY; Lee, K; Le, HHT; Jeon, J; Lee, JE; Huh, W; Ong, SG; Lee, WH; Kim, YG

    FRONT IMMUNOL 2020 10.3389/fimmu.2020.564288

    Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury

    Jang1, HR; Lee, K; Jeon, J; Kim, JR; Lee, JE; Kwon, GY; Kim, YG; Kim, DJ; Ko, JW; Huh, W

    ANN SURG TREAT RES 2020 10.4174/astr.2020.99.1.52

    Perioperative risk factors of progressive chronic kidney disease following liver transplantation analyses of a 10-year follow-up single-center cohort

    Lee1, K; Jeon, J; Kim, JM; Kim, G; Kim, K; Jang, HR; Lee, JE; Joh, JW; Lee, SK; Huh, W

    BMC NEPHROLOGY 2020 10.1186/s12882-020-01825-6

    Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study

    Jeon1, J; Kim, DH; Jang, HR; Lee, JE; Huh, W; Kim, HY; Kim, DJ; Kim, YG

    CLOSE

    Patients' Rights and Responsibilities

    Patients' Rights

    1. Right to receive medical care

    Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

    2. Right to be informed and to make an autonomous decision

    Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

    3. Right to confidentiality

    Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

    4. Right to request consultation and mediation

    In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

    5. Right to have values and beliefs respected

    Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

    6. Right to receive care in a safe setting

    Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

    Patients' Responsibilities

    1. Responsibility to trust and respect the medical team

    Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

    2. Responsibility to not use dishonest methods for medical treatment

    Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

    3. Responsibility to abide by all hospital regulations

    Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.